Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Arquivos de neuro-psiquiatria (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000600429 |
Resumo: | Background Although classical human T-cell lymphocyte virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis syndrome is the most frequent HTLV-1-associated neurological disorder, some “minor” neurological disorders can be seen in “asymptomatic” carriers. These disorders, including cognitive alterations already described in clinical cases and studies, may constitute an intermediate syndrome (IMS) between the asymptomatic state and myelopathy. The aim of this study was to investigate the presence of cognitive deficits in patients with HTLV-1 virus, who usually are diagnosed as asymptomatic. Methods A total of 54 HTLV-1-infected patients were evaluated, 35 asymptomatic and 19 with minor neurological alterations (evaluated by a neurologist); 25 HTLV-1-seronegative individuals served as controls. The instruments used were: Beck’s Depression Inventory, Lawton’s Daily Life Activity Scale, and a complete neuropsychological battery. The application of these evaluation instruments was performed blindly, with the evaluator neuropsychologist not knowing the clinical condition of the patient. Results Most of the participants in this cohort, including seronegative controls, were female (n = 57, 72.21%), their mean age was 52.34 years (SD = 14.29) and their average schooling was 9.70 years (SD = 4.11). Discussion Participants classified with IMS had lower gross scores when compared with both the patients classified as asymptomatic and with the control group, and when tested for auditory episodic memory of immediate (p < 0.01), and late (p = 0.01), recall. Conclusion Patients with IMS presented with memory impairment when compared with asymptomatic patients and seronegative individuals; this is one of the symptoms that aids in the classification of the syndrome. |
id |
ABNEURO-1_1d8bcc12a0b7d1a038f81b2d33dc04e4 |
---|---|
oai_identifier_str |
oai:scielo:S0004-282X2019000600429 |
network_acronym_str |
ABNEURO-1 |
network_name_str |
Arquivos de neuro-psiquiatria (Online) |
repository_id_str |
|
spelling |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients?Human T-lymphotropic virus 1neuropsychological evaluationearly neurocognitive impairment Background Although classical human T-cell lymphocyte virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis syndrome is the most frequent HTLV-1-associated neurological disorder, some “minor” neurological disorders can be seen in “asymptomatic” carriers. These disorders, including cognitive alterations already described in clinical cases and studies, may constitute an intermediate syndrome (IMS) between the asymptomatic state and myelopathy. The aim of this study was to investigate the presence of cognitive deficits in patients with HTLV-1 virus, who usually are diagnosed as asymptomatic. Methods A total of 54 HTLV-1-infected patients were evaluated, 35 asymptomatic and 19 with minor neurological alterations (evaluated by a neurologist); 25 HTLV-1-seronegative individuals served as controls. The instruments used were: Beck’s Depression Inventory, Lawton’s Daily Life Activity Scale, and a complete neuropsychological battery. The application of these evaluation instruments was performed blindly, with the evaluator neuropsychologist not knowing the clinical condition of the patient. Results Most of the participants in this cohort, including seronegative controls, were female (n = 57, 72.21%), their mean age was 52.34 years (SD = 14.29) and their average schooling was 9.70 years (SD = 4.11). Discussion Participants classified with IMS had lower gross scores when compared with both the patients classified as asymptomatic and with the control group, and when tested for auditory episodic memory of immediate (p < 0.01), and late (p = 0.01), recall. Conclusion Patients with IMS presented with memory impairment when compared with asymptomatic patients and seronegative individuals; this is one of the symptoms that aids in the classification of the syndrome.Academia Brasileira de Neurologia - ABNEURO2019-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000600429Arquivos de Neuro-Psiquiatria v.77 n.6 2019reponame:Arquivos de neuro-psiquiatria (Online)instname:Academia Brasileira de Neurologiainstacron:ABNEURO10.1590/0004-282x20190062info:eu-repo/semantics/openAccessGASCON,Maria RitaHAZIOT,Michel EASSONE,TatianeFONSECA,Luiz Augusto MSMID,JerusaOLIVEIRA,Augusto César Penalva deCASSEB,Jorgeeng2019-07-15T00:00:00Zoai:scielo:S0004-282X2019000600429Revistahttp://www.scielo.br/anphttps://old.scielo.br/oai/scielo-oai.php||revista.arquivos@abneuro.org1678-42270004-282Xopendoar:2019-07-15T00:00Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologiafalse |
dc.title.none.fl_str_mv |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
title |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
spellingShingle |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? GASCON,Maria Rita Human T-lymphotropic virus 1 neuropsychological evaluation early neurocognitive impairment |
title_short |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
title_full |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
title_fullStr |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
title_full_unstemmed |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
title_sort |
Memory impairment: an intermediate clinical syndrome symptom in HTLV-1-infected patients? |
author |
GASCON,Maria Rita |
author_facet |
GASCON,Maria Rita HAZIOT,Michel E ASSONE,Tatiane FONSECA,Luiz Augusto M SMID,Jerusa OLIVEIRA,Augusto César Penalva de CASSEB,Jorge |
author_role |
author |
author2 |
HAZIOT,Michel E ASSONE,Tatiane FONSECA,Luiz Augusto M SMID,Jerusa OLIVEIRA,Augusto César Penalva de CASSEB,Jorge |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
GASCON,Maria Rita HAZIOT,Michel E ASSONE,Tatiane FONSECA,Luiz Augusto M SMID,Jerusa OLIVEIRA,Augusto César Penalva de CASSEB,Jorge |
dc.subject.por.fl_str_mv |
Human T-lymphotropic virus 1 neuropsychological evaluation early neurocognitive impairment |
topic |
Human T-lymphotropic virus 1 neuropsychological evaluation early neurocognitive impairment |
description |
Background Although classical human T-cell lymphocyte virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis syndrome is the most frequent HTLV-1-associated neurological disorder, some “minor” neurological disorders can be seen in “asymptomatic” carriers. These disorders, including cognitive alterations already described in clinical cases and studies, may constitute an intermediate syndrome (IMS) between the asymptomatic state and myelopathy. The aim of this study was to investigate the presence of cognitive deficits in patients with HTLV-1 virus, who usually are diagnosed as asymptomatic. Methods A total of 54 HTLV-1-infected patients were evaluated, 35 asymptomatic and 19 with minor neurological alterations (evaluated by a neurologist); 25 HTLV-1-seronegative individuals served as controls. The instruments used were: Beck’s Depression Inventory, Lawton’s Daily Life Activity Scale, and a complete neuropsychological battery. The application of these evaluation instruments was performed blindly, with the evaluator neuropsychologist not knowing the clinical condition of the patient. Results Most of the participants in this cohort, including seronegative controls, were female (n = 57, 72.21%), their mean age was 52.34 years (SD = 14.29) and their average schooling was 9.70 years (SD = 4.11). Discussion Participants classified with IMS had lower gross scores when compared with both the patients classified as asymptomatic and with the control group, and when tested for auditory episodic memory of immediate (p < 0.01), and late (p = 0.01), recall. Conclusion Patients with IMS presented with memory impairment when compared with asymptomatic patients and seronegative individuals; this is one of the symptoms that aids in the classification of the syndrome. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-06-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000600429 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2019000600429 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/0004-282x20190062 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
publisher.none.fl_str_mv |
Academia Brasileira de Neurologia - ABNEURO |
dc.source.none.fl_str_mv |
Arquivos de Neuro-Psiquiatria v.77 n.6 2019 reponame:Arquivos de neuro-psiquiatria (Online) instname:Academia Brasileira de Neurologia instacron:ABNEURO |
instname_str |
Academia Brasileira de Neurologia |
instacron_str |
ABNEURO |
institution |
ABNEURO |
reponame_str |
Arquivos de neuro-psiquiatria (Online) |
collection |
Arquivos de neuro-psiquiatria (Online) |
repository.name.fl_str_mv |
Arquivos de neuro-psiquiatria (Online) - Academia Brasileira de Neurologia |
repository.mail.fl_str_mv |
||revista.arquivos@abneuro.org |
_version_ |
1754212785081810944 |